Why Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 13.85%
As of Monday, November 16, Treace Medical Concepts, Inc.’s TMCI share price has dipped by 13.85%, which has investors questioning if this is right time to buy.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Tudor Pop
Rosalio Madrigal
Jenna Brashear
| Share Statistics | TMCI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $290.4 | $372.7 | 33% |
|
| Shares Out (Mil) | 65.5 | 41.4 | 53% |
|
| Institutional Ownership | 60.0% | 84.0% | 38% |
|
| Float (Mil) | 48.4 | 35.6 | 46% |
|
| Beta | 1.56 | 0.87 | 84% |
|
| Avg Daily Volume (000s) | 475 | 323 | 56% |
|
| Price Change (52-week) |
46.2% | 57.5% | 86% |
|
| Growth | TMCI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 29.9% | 11.8% | 90% |
|
| Net Income (5yr) | (74.0%) | (5.7%) | 4% |
|
| EPS (5yr) | (51.7%) | 10.6% | 3 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.6%) | (15.8%) | 47% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | na | |
| Current EPS | ($0.110) | ($0.811) | ($0.760) | |
| Month Ago EPS | ($0.110) | na | ($0.850) | |
| # Rev Up | 1 | 3 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.110) | na | ($0.850) | |
| Year/Year Chg | (42.7%) | (13.1%) | (26.8%) | |
| Financials | TMCI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $203 | $125 | 32% |
|
| Net Income (TTM) (Mil) | ($56) | ($9) | 15% |
|
| EPS (TTM) | ($0.862) | ($0.300) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | ($9) | ($1) | 21% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $2 | 45% |
|
| Long-Term Debt (Q1) (Mil) | $69 | $21 | 41% |
|
| Enterprise Value (Q1) (Mil) | $325 | $381 | 31% |
|
| Valuation | TMCI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.71 | 2.58 | 80% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | TMCI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 79.6% | 59.5% | 89% |
|
| Net Margin | (27.4%) | (4.5%) | 15% |
|
| ROA | (29.7%) | (10.1%) | 16% |
|
| ROE | (74.0%) | (8.3%) | 11% |
|
| Liabilities to Assets | 65.6% | 45.8% | 61% |
|
| F-Score | 2 | 4 | 7% |
|
Treace Medical Concepts, Inc. did not pass any screens on 11/17/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors